[250 Pages Report] The global microencapsulated omega-3 powders market size is likely to exceed US$ 17.4 Bn in 2032 and exhibit steady growth at a CAGR of 8.2% in the forecast period from 2022 to 2032. Increasing product consumption on the back of changing dietary habits and rising prevalence of cardiovascular diseases is set to push growth.
As per a report by FMI, demand for microencapsulated omega-3 powders is projected to reach US$ 10.5 Bn in 2022. Surging investment by consumers in products associated with their healthcare and wellbeing is anticipated to bode well for the market.
| Report Attribute | Details |
|---|---|
| Microencapsulated Omega-3 Powders Market Estimated Base Year Value (2021) | US$ 9.1 Billion |
| Microencapsulated Omega-3 Powders Market Expected Market Value (2022) | US$ 10.5 Billion |
| Microencapsulated Omega-3 Powders Market Anticipated Forecast Value (2032) | US$ 17.4 Billion |
| Microencapsulated Omega-3 Powders Market Projected Growth Rate (2022-2032) | 8.2% CAGR |
As omega-3 fatty acids help in lowering the risk of arrhythmias or abnormal heartbeats that can even lead to sudden death of patients, demand for omega-3 powders is set to surge in the assessment period. The emergence of microencapsulation technology that is capable of improving the durability of powders even in temperature extremities is likely to push growth.
Besides, the ability of omega-3 fatty acids to lower the levels of triglyceride, reduce blood pressure levels, and slow down the growth of atherosclerotic plaque is expected to propel sales of microencapsulated omega-3 powders in future years. Increasing inclination of consumers towards healthier alternatives and surging adoption of preventive care to lead a better lifestyle are also set to boost growth.
In addition to that, high demand for omega-3 supplements worldwide as they are considered to be a rich source of minerals, proteins, and vitamins is estimated to foster growth. Increasing need to lower the risk of depression, asthma, and cancer among people of all age groups is also likely to drive the market.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Increasing prevalence of cancer and cardiovascular disease stoked by rising health awareness and adoption of a sedentary lifestyle across the globe is anticipated to spur the microencapsulated omega-3 powders market growth in the upcoming years. As per the World Health Organization (WHO), in 2020, cancer accounted for about 10 million deaths or 1 in 6 deaths worldwide. These numbers are projected to surge at a rapid pace in future years, thereby accelerating the market.
The WHO further mentioned that diabetes was considered to be the ninth leading cause of death in 2019, with a projected 1.5 million deaths directly caused by the disease. Also, the number of people suffering from diabetes surged to 422 million in 2014 from 422 million in 2014 with high prevalence in low- and middle-income countries globally. The trend is set to continue during the forthcoming years with changing lifestyles and consumption of junk food, thereby fostering growth.
Conventional omega 3 ingredient producers, especially in emerging economies, find it difficult to provide their products at a competitive price range. It is more relevant for those manufacturers that deliver omega-3 ingredients from alternative sources, such as krill oils and algae oils. Apart from that, consuming very high amounts of omega-3 fatty acids with health supplements can surge blood sugar levels of those people living with diabetes.
Diarrhea is another common side effect of consuming excessive fish oil. Driven by the above-mentioned disadvantages, demand for microencapsulated omega-3 powders may decline in future.
Principal Consultant
North America is anticipated to dominate in the evaluation period by generating the largest microencapsulated omega-3 powders market share. Increasing cases of heart-related issues and obesity in the U.S. and Canada are set to push the need for various health supplements, including microencapsulated omega-3 powders across North America.
Moreover, several manufacturers based in the region are focusing more on developing advanced production technologies. They are thus aiming to reduce oxidation in their manufacturing processes and eliminate environmental pollutants from fish oil. A few North America-based producers are also striving to concentrate omega-3 content in their final products to ensure the delivery of healthy parameters of fish oil.
Increasing awareness among people living in India, China, South Korea, and Japan regarding the benefits of following a healthy diet is projected to augment the Asia Pacific microencapsulated omega-3 powders market size. Increasing population of young mothers and high birth rate across Asia Pacific are also set to spur the demand for infant nutrition, thereby pushing sales.
Additionally, increasing shift of consumers towards plant-based alternatives is compelling manufacturers to produce algae oil-based supplements. Growing vegan population across Asia Pacific is set to fuel sales of plant-based casing materials.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Some of the prominent companies operating in the global microencapsulated omega-3 powders market include Clover Corporation, Venketesh Biosciences LLP, Novotech Nutrition, Socius Ingredients, Koninklijke DSM N.V., KD Pharma Group, BASF SE, Wincobel, Skuny Bioscience Co., Ltd., Stepan Company, Glanbia Nutritionals, Biosearch SA and Benexia among others.
The global market is highly competitive in nature with the presence of various local and international key players. They are mainly focusing on developing well-differentiated products to generate high market share. Some of the other key players are aiming to use non-fish sources for omega-3 extraction backed by the increasing trend of veganism in various parts of the globe. They are striving to find new algal sources as these do not have a fishy odor or taste, thereby making omega-3 ideal for the vegan population.
| Report Attribute | Details |
|---|---|
| Growth Rate | CAGR of 8.2% from 2022 to 2032 |
| Base Year for Estimation | 2021 |
| Historical Data | 2015-2020 |
| Forecast Period | 2022-2032 |
| Quantitative Units | Revenue in US$ Million and CAGR from 2022-2032 |
| Report Coverage | Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis |
| Segments Covered |
|
| Regions Covered |
|
| Key Countries Profiled |
|
| Key Companies Profiled |
|
| Customization | Available Upon Request |
The global microencapsulated omega-3 powders market is set to surpass US$ 17.4 Bn in 2032.
North America is set to lead the microencapsulated omega-3 powders market in the forecast period.
Clover Corporation, Venketesh Biosciences LLP, Novotech Nutrition, Socius Ingredients, Koninklijke DSM N.V., KD Pharma Group, BASF SE, and Wincobel some of the renowned companies in the microencapsulated omega-3 powders market.
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Product Life Cycle Analysis 3.5. Supply Chain Analysis 3.5.1. Supply Side Participants and their Roles 3.5.1.1. Producers 3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers) 3.5.1.3. Wholesalers and Distributors 3.5.2. Value Added and Value Created at Node in the Supply Chain 3.5.3. List of Raw Material Suppliers 3.5.4. List of Existing and Potential Buyer’s 3.6. Investment Feasibility Matrix 3.7. Value Chain Analysis 3.7.1. Profit Margin Analysis 3.7.2. Wholesalers and Distributors 3.7.3. Retailers 3.8. PESTLE and Porter’s Analysis 3.9. Regulatory Landscape 3.9.1. By Key Regions 3.9.2. By Key Countries 3.10. Regional Parent Market Outlook 3.11. Production and Consumption Statistics 3.12. Import and Export Statistics 4. Global Microencapsulated Omega-3 Powders Market Analysis 2017-2021 and Forecast, 2022-2032 4.1. Historical Market Size Value (US$ Mn) & Volume (Tons) Analysis, 2017-2021 4.2. Current and Future Market Size Value (US$ Mn) & Volume (Tons) Projections, 2022-2032 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Microencapsulated Omega-3 Powders Market Analysis 2017-2021 and Forecast 2022-2032, By Nature 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Mn) & Volume (Tons) Analysis By Nature, 2017-2021 5.3. Current and Future Market Size Value (US$ Mn) & Volume (Tons) Analysis and Forecast By Nature, 2022-2032 5.3.1. Organic 5.3.2. Conventional 5.4. Y-o-Y Growth Trend Analysis By Nature, 2017-2021 5.5. Absolute $ Opportunity Analysis By Nature, 2022-2032 6. Global Microencapsulated Omega-3 Powders Market Analysis 2017-2021 and Forecast 2022-2032, By Distribution Channel 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Mn) & Volume (Tons) Analysis By Distribution Channel, 2017-2021 6.3. Current and Future Market Size Value (US$ Mn) & Volume (Tons) Analysis and Forecast By Distribution Channel, 2022-2032 6.3.1. Direct 6.3.2. Indirect 6.3.2.1. Store-based 6.3.2.2. Supermarket/Hypermarket 6.3.2.3. Convenience Stores 6.3.2.4. Discount Stores 6.3.2.5. Food and Drink Health Stores 6.3.2.6. Online 6.4. Y-o-Y Growth Trend Analysis By Distribution Channel, 2017-2021 6.5. Absolute $ Opportunity Analysis By Distribution Channel, 2022-2032 7. Global Microencapsulated Omega-3 Powders Market Analysis 2017-2021 and Forecast 2022-2032, By Type 7.1. Introduction / Key Findings 7.2. Historical Market Size Value (US$ Mn) & Volume (Tons) Analysis By Type, 2017-2021 7.3. Current and Future Market Size Value (US$ Mn) & Volume (Tons) Analysis and Forecast By Type, 2022-2032 7.3.1. Alpha-linolenic Acid 7.3.2. Eicosapentaenoic Acid 7.3.3. Docosahexaenoic Acid 7.4. Y-o-Y Growth Trend Analysis By Type, 2017-2021 7.5. Absolute $ Opportunity Analysis By Type, 2022-2032 8. Global Microencapsulated Omega-3 Powders Market Analysis 2017-2021 and Forecast 2022-2032, By Region 8.1. Introduction 8.2. Historical Market Size Value (US$ Mn) & Volume (Tons) Analysis By Region, 2017-2021 8.3. Current Market Size Value (US$ Mn) & Volume (Tons) Analysis and Forecast By Region, 2022-2032 8.3.1. North America 8.3.2. Latin America 8.3.3. Europe 8.3.4. Asia Pacific 8.3.5. MEA 8.4. Market Attractiveness Analysis By Region 9. North America Microencapsulated Omega-3 Powders Market Analysis 2017-2021 and Forecast 2022-2032, By Country 9.1. Historical Market Size Value (US$ Mn) & Volume (Tons) Trend Analysis By Market Taxonomy, 2017-2021 9.2. Market Size Value (US$ Mn) & Volume (Tons) Forecast By Market Taxonomy, 2022-2032 9.2.1. By Country 9.2.1.1. U.S. 9.2.1.2. Canada 9.2.2. By Nature 9.2.3. By Distribution Channel 9.2.4. By Type 9.3. Market Attractiveness Analysis 9.3.1. By Country 9.3.2. By Nature 9.3.3. By Distribution Channel 9.3.4. By Type 9.4. Key Takeaways 10. Latin America Microencapsulated Omega-3 Powders Market Analysis 2017-2021 and Forecast 2022-2032, By Country 10.1. Historical Market Size Value (US$ Mn) & Volume (Tons) Trend Analysis By Market Taxonomy, 2017-2021 10.2. Market Size Value (US$ Mn) & Volume (Tons) Forecast By Market Taxonomy, 2022-2032 10.2.1. By Country 10.2.1.1. Brazil 10.2.1.2. Mexico 10.2.1.3. Rest of Latin America 10.2.2. By Nature 10.2.3. By Distribution Channel 10.2.4. By Type 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Nature 10.3.3. By Distribution Channel 10.3.4. By Type 10.4. Key Takeaways 11. Europe Microencapsulated Omega-3 Powders Market Analysis 2017-2021 and Forecast 2022-2032, By Country 11.1. Historical Market Size Value (US$ Mn) & Volume (Tons) Trend Analysis By Market Taxonomy, 2017-2021 11.2. Market Size Value (US$ Mn) & Volume (Tons) Forecast By Market Taxonomy, 2022-2032 11.2.1. By Country 11.2.1.1. Germany 11.2.1.2. U.K. 11.2.1.3. France 11.2.1.4. Spain 11.2.1.5. Italy 11.2.1.6. Rest of Europe 11.2.2. By Nature 11.2.3. By Distribution Channel 11.2.4. By Type 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Nature 11.3.3. By Distribution Channel 11.3.4. By Type 11.4. Key Takeaways 12. Asia Pacific Microencapsulated Omega-3 Powders Market Analysis 2017-2021 and Forecast 2022-2032, By Country 12.1. Historical Market Size Value (US$ Mn) & Volume (Tons) Trend Analysis By Market Taxonomy, 2017-2021 12.2. Market Size Value (US$ Mn) & Volume (Tons) Forecast By Market Taxonomy, 2022-2032 12.2.1. By Country 12.2.1.1. China 12.2.1.2. Japan 12.2.1.3. South Korea 12.2.1.4. Malaysia 12.2.1.5. Singapore 12.2.1.6. Australia 12.2.1.7. New Zealand 12.2.1.8. Rest of APAC 12.2.2. By Nature 12.2.3. By Distribution Channel 12.2.4. By Type 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Nature 12.3.3. By Distribution Channel 12.3.4. By Type 12.4. Key Takeaways 13. MEA Microencapsulated Omega-3 Powders Market Analysis 2017-2021 and Forecast 2022-2032, By Country 13.1. Historical Market Size Value (US$ Mn) & Volume (Tons) Trend Analysis By Market Taxonomy, 2017-2021 13.2. Market Size Value (US$ Mn) & Volume (Tons) Forecast By Market Taxonomy, 2022-2032 13.2.1. By Country 13.2.1.1. GCC Countries 13.2.1.2. South Africa 13.2.1.3. Israel 13.2.1.4. Rest of MEA 13.2.2. By Nature 13.2.3. By Distribution Channel 13.2.4. By Type 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Nature 13.3.3. By Distribution Channel 13.3.4. By Type 13.4. Key Takeaways 14. Key Countries Microencapsulated Omega-3 Powders Market Analysis 14.1. U.S. 14.1.1. Pricing Analysis 14.1.2. Market Share Analysis, 2021 14.1.2.1. By Nature 14.1.2.2. By Distribution Channel 14.1.2.3. By Type 14.2. Canada 14.2.1. Pricing Analysis 14.2.2. Market Share Analysis, 2021 14.2.2.1. By Nature 14.2.2.2. By Distribution Channel 14.2.2.3. By Type 14.3. Brazil 14.3.1. Pricing Analysis 14.3.2. Market Share Analysis, 2021 14.3.2.1. By Nature 14.3.2.2. By Distribution Channel 14.3.2.3. By Type 14.4. Mexico 14.4.1. Pricing Analysis 14.4.2. Market Share Analysis, 2021 14.4.2.1. By Nature 14.4.2.2. By Distribution Channel 14.4.2.3. By Type 14.5. Germany 14.5.1. Pricing Analysis 14.5.2. Market Share Analysis, 2021 14.5.2.1. By Nature 14.5.2.2. By Distribution Channel 14.5.2.3. By Type 14.6. U.K. 14.6.1. Pricing Analysis 14.6.2. Market Share Analysis, 2021 14.6.2.1. By Nature 14.6.2.2. By Distribution Channel 14.6.2.3. By Type 14.7. France 14.7.1. Pricing Analysis 14.7.2. Market Share Analysis, 2021 14.7.2.1. By Nature 14.7.2.2. By Distribution Channel 14.7.2.3. By Type 14.8. Spain 14.8.1. Pricing Analysis 14.8.2. Market Share Analysis, 2021 14.8.2.1. By Nature 14.8.2.2. By Distribution Channel 14.8.2.3. By Type 14.9. Italy 14.9.1. Pricing Analysis 14.9.2. Market Share Analysis, 2021 14.9.2.1. By Nature 14.9.2.2. By Distribution Channel 14.9.2.3. By Type 14.10. China 14.10.1. Pricing Analysis 14.10.2. Market Share Analysis, 2021 14.10.2.1. By Nature 14.10.2.2. By Distribution Channel 14.10.2.3. By Type 14.11. Japan 14.11.1. Pricing Analysis 14.11.2. Market Share Analysis, 2021 14.11.2.1. By Nature 14.11.2.2. By Distribution Channel 14.11.2.3. By Type 14.12. South Korea 14.12.1. Pricing Analysis 14.12.2. Market Share Analysis, 2021 14.12.2.1. By Nature 14.12.2.2. By Distribution Channel 14.12.2.3. By Type 14.13. Malaysia 14.13.1. Pricing Analysis 14.13.2. Market Share Analysis, 2021 14.13.2.1. By Nature 14.13.2.2. By Distribution Channel 14.13.2.3. By Type 14.14. Singapore 14.14.1. Pricing Analysis 14.14.2. Market Share Analysis, 2021 14.14.2.1. By Nature 14.14.2.2. By Distribution Channel 14.14.2.3. By Type 14.15. Australia 14.15.1. Pricing Analysis 14.15.2. Market Share Analysis, 2021 14.15.2.1. By Nature 14.15.2.2. By Distribution Channel 14.15.2.3. By Type 14.16. New Zealand 14.16.1. Pricing Analysis 14.16.2. Market Share Analysis, 2021 14.16.2.1. By Nature 14.16.2.2. By Distribution Channel 14.16.2.3. By Type 14.17. GCC Countries 14.17.1. Pricing Analysis 14.17.2. Market Share Analysis, 2021 14.17.2.1. By Nature 14.17.2.2. By Distribution Channel 14.17.2.3. By Type 14.18. South Africa 14.18.1. Pricing Analysis 14.18.2. Market Share Analysis, 2021 14.18.2.1. By Nature 14.18.2.2. By Distribution Channel 14.18.2.3. By Type 14.19. Israel 14.19.1. Pricing Analysis 14.19.2. Market Share Analysis, 2021 14.19.2.1. By Nature 14.19.2.2. By Distribution Channel 14.19.2.3. By Type 15. Market Structure Analysis 15.1. Competition Dashboard 15.2. Competition Benchmarking 15.3. Market Share Analysis of Top Players 15.3.1. By Regional 15.3.2. By Nature 15.3.3. By Distribution Channel 15.3.4. By Type 16. Competition Analysis 16.1. Competition Deep Dive 16.1.1. KD Pharma Group 16.1.1.1. Overview 16.1.1.2. Product Portfolio 16.1.1.3. Profitability by Market Segments 16.1.1.4. Sales Footprint 16.1.1.5. Strategy Overview 16.1.1.5.1. Marketing Strategy 16.1.1.5.2. Product Strategy 16.1.1.5.3. Channel Strategy 16.1.2. Venketesh Biosciences LLP 16.1.2.1. Overview 16.1.2.2. Product Portfolio 16.1.2.3. Profitability by Market Segments 16.1.2.4. Sales Footprint 16.1.2.5. Strategy Overview 16.1.2.5.1. Marketing Strategy 16.1.2.5.2. Product Strategy 16.1.2.5.3. Channel Strategy 16.1.3. Wincobel 16.1.3.1. Overview 16.1.3.2. Product Portfolio 16.1.3.3. Profitability by Market Segments 16.1.3.4. Sales Footprint 16.1.3.5. Strategy Overview 16.1.3.5.1. Marketing Strategy 16.1.3.5.2. Product Strategy 16.1.3.5.3. Channel Strategy 16.1.4. Stepan Company 16.1.4.1. Overview 16.1.4.2. Product Portfolio 16.1.4.3. Profitability by Market Segments 16.1.4.4. Sales Footprint 16.1.4.5. Strategy Overview 16.1.4.5.1. Marketing Strategy 16.1.4.5.2. Product Strategy 16.1.4.5.3. Channel Strategy 16.1.5. Socius Ingredients 16.1.5.1. Overview 16.1.5.2. Product Portfolio 16.1.5.3. Profitability by Market Segments 16.1.5.4. Sales Footprint 16.1.5.5. Strategy Overview 16.1.5.5.1. Marketing Strategy 16.1.5.5.2. Product Strategy 16.1.5.5.3. Channel Strategy 16.1.6. Benexia 16.1.6.1. Overview 16.1.6.2. Product Portfolio 16.1.6.3. Profitability by Market Segments 16.1.6.4. Sales Footprint 16.1.6.5. Strategy Overview 16.1.6.5.1. Marketing Strategy 16.1.6.5.2. Product Strategy 16.1.6.5.3. Channel Strategy 16.1.7. Biosearch 16.1.7.1. Overview 16.1.7.2. Product Portfolio 16.1.7.3. Profitability by Market Segments 16.1.7.4. Sales Footprint 16.1.7.5. Strategy Overview 16.1.7.5.1. Marketing Strategy 16.1.7.5.2. Product Strategy 16.1.7.5.3. Channel Strategy 16.1.8. Glanbia Nutritionals 16.1.8.1. Overview 16.1.8.2. Product Portfolio 16.1.8.3. Profitability by Market Segments 16.1.8.4. Sales Footprint 16.1.8.5. Strategy Overview 16.1.8.5.1. Marketing Strategy 16.1.8.5.2. Product Strategy 16.1.8.5.3. Channel Strategy 16.1.9. Clover Corporation 16.1.9.1. Overview 16.1.9.2. Product Portfolio 16.1.9.3. Profitability by Market Segments 16.1.9.4. Sales Footprint 16.1.9.5. Strategy Overview 16.1.9.5.1. Marketing Strategy 16.1.9.5.2. Product Strategy 16.1.9.5.3. Channel Strategy 16.1.10. Skuny Bioscience Co., Ltd. 16.1.10.1. Overview 16.1.10.2. Product Portfolio 16.1.10.3. Profitability by Market Segments 16.1.10.4. Sales Footprint 16.1.10.5. Strategy Overview 16.1.10.5.1. Marketing Strategy 16.1.10.5.2. Product Strategy 16.1.10.5.3. Channel Strategy 16.1.11. BASF SE 16.1.11.1. Overview 16.1.11.2. Product Portfolio 16.1.11.3. Profitability by Market Segments 16.1.11.4. Sales Footprint 16.1.11.5. Strategy Overview 16.1.11.5.1. Marketing Strategy 16.1.11.5.2. Product Strategy 16.1.11.5.3. Channel Strategy 16.1.12. Novotech Nutrition 16.1.12.1. Overview 16.1.12.2. Product Portfolio 16.1.12.3. Profitability by Market Segments 16.1.12.4. Sales Footprint 16.1.12.5. Strategy Overview 16.1.12.5.1. Marketing Strategy 16.1.12.5.2. Product Strategy 16.1.12.5.3. Channel Strategy 16.1.13. Koninklijke DSM N.V. 16.1.13.1. Overview 16.1.13.2. Product Portfolio 16.1.13.3. Profitability by Market Segments 16.1.13.4. Sales Footprint 16.1.13.5. Strategy Overview 16.1.13.5.1. Marketing Strategy 16.1.13.5.2. Product Strategy 16.1.13.5.3. Channel Strategy 17. Assumptions & Acronyms Used 18. Research Methodology
Explore Food and Beverage Insights
View Reports
Microencapsulated Omega-3 Powders Market
